ACS Combinatorial Science ( IF 3.903 ) Pub Date : 2020-12-14 , DOI:
10.1021/acscombsci.0c00181
MGFinn
This is the final issue of ACS Combinatorial Science. I write these words with a profound sense of gratitude to the many authors and reviewers who have contributed to its pages, to our Editorial Advisory Board members who have provided wise counsel, and to the small but mighty group of associate editors and staff who have made the journal a joy to put together. I also write with both sadness and confidence at the literal and figurative turning of the page that the journal’s closing represents. Volume 1 of the Journal of Combinatorial Chemistry appeared on Jan. 12, 1999, under the direction of Founding Editor-in-Chief Anthony W. Czarnik. Tony was involved in the combi-chem revolution from its earliest days, when the idea of making and testing libraries of potential small-molecule drugs was new, and the nascent field was dominated by concerns about how parallel synthesis could be done and how compounds could be adequately characterized. New instruments for parallel reactions and purifications were all the rage, new ideas for molecular tagging or bead sorting were eagerly traded at meetings, and companies were founded and folded at a dizzying pace. But the heart of the Journal of Combinatorial Chemistry was always the chemistry: good reactions discovered and optimized for the synthesis of potentially useful molecular structures. The potential power of the field, at least to those moving into it, was obvious. For the most part, I shall not cite particular papers here, for fear of leaving out countless worthy contributions. But, for me, a 1996 review(1) by Wayne Guida and colleagues was critical to my appreciation of the subject. It posed the startling hypothesis that the potential size of the ultimate library of drug-like molecules was essentially infinite, estimated at up to 1063 distinct structures. This suggested that there must be a very large number of chemical answers to every question in any field that relied on molecular structure and properties. How to find some of those answers became a motivating concern for a substantial number of investigators, and the field of combinatorial chemistry was born. I succeeded Dr. Czarnik as Editor-in-Chief in late 2010, understanding that the field of drug discovery had undergone a revolution with the rollout of the first monoclonal antibody blockbuster, Humira (adalimumab). Antibodies are made by combinatorial synthesis and screening, whether by the immune system or by the laboratory investigator using techniques such as phage display. In appreciation of this, and a parallel understanding that the properties of polymeric materials and other systems of interacting molecular components were being developed by new methods of synthesis and analysis, the ACS agreed to change the name of the journal to ACS Combinatorial Science. As we wrote then, “The name change signals an expansion of the journal’s scope to include combinatorial and evolutionary approaches to problems in biology, molecular biology, materials science, and catalysis development, in addition to the journal’s traditional focus on synthetic chemistry methods and high-throughput drug discovery.” And we were off on a very interesting ride. ACS Combinatorial Science was the first and only ACS journal to be devoted to a way of doing science, rather than to a specific field of knowledge or application. It was perhaps, therefore, destined to be transient, since methods change. It is now undeniable that combinatorial approaches are woven deeply into the fabric of modern therapeutic development. Few companies pursuing a new small-molecule drug would think twice about making a candidate library to probe structure–activity relationships in a scaffold family, and every biotech startup, or academic laboratory in chemical biology for that matter, has at its fingertips powerful tools for generating and testing biomolecular libraries of immense size. The fields that use solid-state and polymeric materials, from photoelectronics to hydrogels to nanotechnology, now have at their disposal well-accepted methods of making and testing candidates of varying composition. New analytical methods have always been a vital part of combinatorial exploration, and these are now widely distributed and ever improving. Thus, at least the initial development of combinatorial molecular science and technology may be considered complete. Its impact has been profound, and its methods will continue to shape our world and help answer society’s most critical challenges. New chemistry will always infuse library synthesis and materials development. Biomolecular evolution will continue to grow in power and sophistication. And new excitement in such areas as machine learning and DNA-encoded libraries will continue to appear. I will look for all of these in the pages of other journals that cover an enormous range of subjects. And I commend all of you readers of this journal to many happy interactions in the combinatorial enterprise that is research itself and to the insights and discoveries that emerge from them. Views expressed in this editorial are those of the author and not necessarily the views of the ACS. This article references 1 other publications.